Pei Ge

Pei brings over 20 years of experience in drug discovery and development in the biotechnology and pharmaceutical industries to her role as Head of Pharmacology at Triplet Therapeutics, Inc. Prior to joining the company, she was Senior Principal Investigator and Leader of Visceral Pain Research at Ironwood Pharmaceuticals, where she led translational programs that considerably broadened the path for Linzess® and related guanylate cyclase-C agonist peptides of this class as novel drugs for the treatment of chronic pelvic pain syndromes. Prior to her role at Ironwood Pharmaceuticals, she was a senior scientist at Alnylam Pharmaceuticals, where she led the Huntington’s disease program and several other CNS siRNA delivery and therapeutic programs. Pei received her Ed.M. from Harvard University and her B.S. from Stonehill College.